跳至主要内容
临床试验/NCT01560169
NCT01560169已完成不适用

Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients

Alvine Pharmaceuticals Inc.10 个研究点 分布在 2 个国家目标入组 110 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
10
主要终点
Change in symptoms using patient reported outcome instruments

研究概览

简要总结

This is an evaluation of celiac-specific patient reported outcome instruments in celiac disease patients.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of biopsy proven celiac disease
  • Adherence to a gluten-free diet (established patients only)
  • TG2 negative (established patients only)
  • TG2 positive (newly diagnosed patients only)
  • Signed informed consent

排除标准

  • History of IgE-mediated reactions to gluten
  • Significant laboratory abnormalities
  • History of untreated or GI disease
  • Positive pregnancy test
  • Any medical condition which could adversely affect study participation

结局指标

主要结局

Change in symptoms using patient reported outcome instruments

时间窗: 8 and 12 weeks

Sensitivity of the patient reported outcome instruments to detect change over time in celiac disease symptoms with and without a gluten challenge

次要结局

  • Safety - incidence of adverse events(8 and 12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Evaluation of Patient Reported Outcome Instruments... | 临床试验